However, indications that REV1 inhibition can also switch the underlying biology of cancer cells, whereby it can suppress apoptosis in cisplatin-treated cells and trigger senescence [8], suggested that REV1 may have a larger new role in cancer pathogenesis. This evidence concerns the gene REV1 and cancer.